Showing 20 of 56 recruiting trials for “vaginal-carcinoma”
Anti-CD70-CAR-T Cell Injection for the Treatment of Locally Advanced or Relapsed/Metastatic CD70+ Inoperable Renal Cells
Memory-like Natural Killer (NK) Cell Therapy in Patients With Renal Cell Carcinoma or Urothelial Carcinoma
RecruitingNCT06720532 ↗
Kidney Function and Risk Factors in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC) Undergoing 177Lutetium-PSMA Radioligand Therapy: a Prospective Observational Study - KiRi-Trial
68Ga-C1 PET/ CT Imaging in Clear Cell Renal Cell Carcinoma
CBM588 Capsules in Combination With Nivolumab and Ipilimumab for the Treatment of Advanced Stage Kidney Cancer
RecruitingNCT06548867 ↗
Retrospective Analysis of Patients With Metastatic Renal Cell Carcinoma Treated With CABOzantinib
Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program
A Study of SPX-303, a Bispecific Antibody Targeting LILRB2 and PD-L1 in Patients With Solid Tumors
"Embolization Before Ablation of Renal Cell Carcinoma (EMBARC)"
Sequential Treatment of Cabozantinib for Advanced Renal Cell Carcinoma (RCC)
👨⚕️ Tian Zhang, MD, University of Texas Southwestern Medical Center📍 1 site📅 Started Dec 2023View details ↗
A Clinical Research About CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors
👨⚕️ Fei Li, M.D, The First Affiliated Hospital of Nanchang University📍 1 site📅 Started Nov 2023View details ↗
A Study of AK104 Plus Axitinib in Advanced/Metastatic Special Pathological Subtypes of Renal Cell Carcinoma
Locally Ablative TherapY in Oligo-ProgressiVe GEnitourinary TumoRs (LAYOVER)
RecruitingNCT06391879 ↗
Establishment of a Multidimensional Prediction Model for the Natural Course of VHL Disease-related Renal Cell Carcinoma
RecruitingNCT06076538 ↗
PET/MR for Characterization of Renal Masses (RMs)
👨⚕️ Ivan Pedrosa, MD, PhD, University of Texas Southwestern Medical Center📍 1 site📅 Started Aug 2023View details ↗
Combination of 177Lu-TLX250 and Peposertib in Patients With Carbonic Anhydrase IX -Expressing Solid Tumors
Neoadjuvant of Axitinib Plus PD-1 to Improve Disease Free Survival of Patients With Renal Cell Carcinoma
👨⚕️ Fangjian Zhou, Professor, Director of Dept. of Urology, Sun Yat-sen University Cancer Center📍 8 sites📅 Started Apr 2023View details ↗
RecruitingNCT05184790 ↗
LEARN: Learning Environment for Artificial Intelligence in Radiotherapy New Technology
Genetic Testing to Select Therapy for the Treatment of Advanced or Metastatic Kidney Cancer, OPTIC RCC Study
👨⚕️ Brian I Rini, MD, Vanderbilt University/Ingram Cancer Center📍 6 sites📅 Started Dec 2022View details ↗
A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →